Analysis of Acid-Fast Bacilli (AFB) Conversion at the 2nd and 5th Months in Tuberculosis Patients with and without Diabetes Mellitus

Chylen Setiyo Rini, Sukma Nilawati

Abstract


Tuberculosis (TB) remains a major global health problem and is often associated with comorbidities such as Diabetes Mellitus (DM). DM can impair immune response and may delay sputum smear conversion during TB treatment. This study aimed to analyze the difference in Acid-Fast Bacilli (AFB) smear conversion at the 2nd and 5th months between TB patients with DM and those without DM. This study used a descriptive comparative design with secondary data from TB patients recorded in 2023–2024 at the Sepulu Community Health Center Laboratory, Bangkalan, Madura. A total of 117 patients met the inclusion criteria. Data were analyzed using the Chi-square test with SPSS version 25. The results showed a significant difference in AFB smear conversion between TB-DM and TB non-DM patients. At the 2nd month, a significant difference was found (p < 0.001). Similarly, at the 5th month, a significant difference was observed (p = 0.009). TB patients with DM tended to experience slower sputum smear conversion compared with patients without DM. These findings indicate that Diabetes Mellitus may influence the effectiveness of TB treatment, particularly in the sputum conversion phase.

Keywords


Tuberculosis, Diabetes Mellitus, AFB smear conversion

Full Text:

PDF

References


Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World J Diabetes. 2024 May;15(5):853–66.

Adawiyah Putri Diana, Ronald Pratama Adiwinoto, Retno Budiarti, Soedarsono, Hanung Prasetya ONP. Exploring Diabetes Mellitus ’ Impact on Tuberculosis Outcomes : A Comprehensive Comparative Study. J Epidemiol Public Heal (2025),. 2025;10:159–70.

Alkabab Y, Warkentin J, Cummins J, Katz B, Denison BM, Bartok A, et al. Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus. Int J Tuberc lung Dis Off J Int Union against Tuberc Lung Dis. 2023 Feb;27(2):135–9.

Mokti K, Md Isa Z, Sharip J, Abu Bakar SN, Atil A, Hayati F, et al. Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study. Medicine (Baltimore). 2021 Aug;100(31):e26841.

Asemahagn MA. Sputum smear conversion and associated factors among smear ‑ positive pulmonary tuberculosis patients in East Gojjam Zone , Northwest Ethiopia : a longitudinal study. BMC Pulm Med [Internet]. 2021;1–10. Available from: https://doi.org/10.1186/s12890-021-01483-w

do Socorro Nantua Evangelista M, Maia R, Toledo JP, de Abreu RG, Braga JU, Barreira D, et al. Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil. BMC Res Notes. 2018 Jun;11(1):414.

Ali S, Rahman NR, Ashraf, Rumman, Naveed A, Ghafoor A, et al. Comparative Analysis of Culture and Sputum Smear Conversion Timelines and Their Associated Factors in Smokers Versus Non-smokers With Drug-Resistant Tuberculosis. Cureus. 2025 Mar;17(3):e80704.

Dousa KM, Hamad A, Albirair M, Al Soub H, Elzouki AN, Alwakeel MI, et al. Impact of Diabetes Mellitus on the Presentation and Response to Treatment of Adults With Pulmonary Tuberculosis in Qatar. Open forum Infect Dis. 2019 Jan;6(1):ofy335.

Siddiqui AN, Khayyam KU, Sharma M. Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study. Biomed Res Int. 2016;2016:7273935.

Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L, et al. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective. Explor (Beijing, China). 2024 Oct;4(5):20230138.

Boadu AA, Yeboah-Manu M, Osei-Wusu S, Yeboah-Manu D. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions. Int J Infect Dis [Internet]. 2024;146:107140. Available from: https://www.sciencedirect.com/science/article/pii/S120197122400211X

Barry SE, Sawka A, Maldari A, Inauen J, LaBroome S, Geake JB. Macrophage Dysfunction in Tuberculosis–Diabetes Mellitus Comorbidity: A Scoping Review of Immune Dysregulation and Disease Progression. Diabetology [Internet]. 2025;6(5). Available from: https://www.mdpi.com/2673-4540/6/5/35

Diktanas S, Vasiliauskiene E, Polubenko K, Danila E, Celedinaite I, Boreikaite E, et al. Factors Associated with Persistent Sputum Positivity at the End of the Second Month of Tuberculosis Treatment in Lithuania. Tuberc Respir Dis (Seoul). 2018 Jul;81(3):233–40.

Buatong W, Chaimay B, Woradet S. Determinants of sputum smear non-conversion after intensive phase treatment among pulmonary TB patients in southern Thailand. J Infect Dev Ctries. 2019;

Magodoro IM, Kotze LA, Stek CJ, West A, Le Roux A, Sobratee N, et al. Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. Expert Opin Pharmacother. 2025 Jun;26(9):1099–112.

Song C, Xie W, Gong L, Ren M, Pan P, Luo B. The relationship between HbA1c control levels and antituberculosis treatment effects: a meta-analysis. J Chin Med Assoc. 2019 Dec;82(12):915–21.

Putra ON, Rizkiyah F. Impact Of Uncontrolled Hba1c On The Outcome Of Tuberculosis Treatment In Tb Patients With Diabetes. J Profesi Med J Kedokt dan Kesehat. 2020;14(2):210–20.

Gallardo CR, Rigau Comas D, Valderrama Rodríguez A, Roqué i Figuls M, Parker LA, Caylà J, et al. Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis. Cochrane database Syst Rev. 2016 May;2016(5):CD009913.

Shariff NM, Safian N. Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study. Int J mycobacteriology. 2015 Dec;4(4):323–9.

Rahami NA, Dewi R, Shodikin MA. Diabetes Mellitus Associated with Sputum Conversion Time in Drug-Resistant Pulmonary TB Patients at Dr . Soebandi Regional General Hospital , Jember. J Respi. 2024;10(79):195–202.




DOI: https://doi.org/10.30602/jlk.v9i2.2128

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Jurnal Laboratorium Khatulistiwa

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.



JURNAL LABORATORIUM KHATULISTIWA (JLK)

Jurnal Laboratorium Khatulistiwa (JLK) (Print ISSN: 2597-9523 | e-ISSN: 2597-9531 ) is a peer-reviewed open-access scientific journal published by the Department of Medical Laboratory Technology, Poltekkes Kemenkes Pontianak. This journal focuses on the development of medical laboratory science and technology.



Jurnal Laboratorium Khatulistiwa is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License .
CONTACT
✉ jurnallaboratoriumkhatulistiwa@poltekkes-pontianak.ac.id
📍 Poltekkes Kemenkes Pontianak, Jl. 28 Oktober Siantan Hulu, Pontianak, Kalimantan Barat, Indonesia



COLLABORATION
© Poltekkes Kemenkes Pontianak - Jurnal Laboratorium Khatulistiwa (JLK)